Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MSR1 encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of MSR1. Additionally we are shipping Macrophage Scavenger Receptor 1 Kits (17) and Macrophage Scavenger Receptor 1 Proteins (15) and many more products for this protein.
Showing 10 out of 146 products:
Mouse (Murine) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for EIA, FACS - ABIN181780
de Villiers, Fraser, Hughes, Doyle, Gordon: Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. in The Journal of experimental medicine 1994
Show all 11 references for ABIN181780
Mouse (Murine) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN319577
Hughes, Fraser, Gordon: Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. in European journal of immunology 1995
Show all 10 references for ABIN319577
Mouse (Murine) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for EIA, Func - ABIN181779
Bell, Lopez-Gonzalez, Lawson, Hughes, Fraser, Gordon, Perry: Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. in Journal of neurocytology 1995
Show all 6 references for ABIN181779
Mouse (Murine) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN181777
Daugherty, Whitman, Block, Rateri: Polymorphism of class A scavenger receptors in C57BL/6 mice. in Journal of lipid research 2001
Show all 6 references for ABIN181777
Mouse (Murine) Monoclonal Macrophage Scavenger Receptor 1 Primary Antibody for FACS - ABIN181781
Fraser, Hughes, Gordon: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. in Nature 1993
Show all 6 references for ABIN181781
Human Polyclonal Macrophage Scavenger Receptor 1 Primary Antibody for WB - ABIN1537159
Chen, Li, Zhu: AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-?B/LOX-1 pathway. in Vascular pharmacology 2015
Identifying N-linked glycan moiety and motifs in the cysteine-rich domain critical for N-glycosylation and intracellular trafficking of SR-AI and MARCO (show MARCO Antibodies).
The P275A Polymorphism in the Macrophage Scavenger Receptor 1 Gene is not associated with Prostate Cancer Risk.
Cyr61 (show CYR61 Antibodies) promotes CD204 expression and the migration of macrophages via MEK (show MAP2K1 Antibodies)/ERK (show EPHB2 Antibodies) pathway in esophageal squamous cell carcinoma
miR (show MLXIP Antibodies)-29a promotes scavenger receptor A expression by targeting QKI (show QKI Antibodies) during monocyte-macrophage differentiation.
Heptapeptide XD4 activates the class A scavenger receptor (SR-A) on the glia by increasing the binding of Abeta (show APP Antibodies) to SR-A, thereby promoting glial phagocytosis of Abeta (show APP Antibodies) oligomer in microglia.
The truncating variant Arg293X in the gene encoding SRA (show SRA1 Antibodies)-I/II was associated with reduced lung function and with increased risk of COPD (show ARCN1 Antibodies) among men, as well as among alpha1-antitrypsin MZ and superoxide dismutase (show SOD1 Antibodies)-3 E1I1 heterozygotes.
monomeric collagen type I via CD204 induces phospho-Akt (show AKT1 Antibodies) expression shifting alveolar macrophages to the profibrotic M2 type. Innate immune responses induced by collagen monomers might perpetuate pulmonary fibrosis.
There was a significant negative correlation between the number of CD163 (show CD163 Antibodies)(+), CD204(+) or CD206 (show MRC1 Antibodies)(+) alveolar macrophages.
rs6966 (3' UTR of PPP1R13L, chr 19q13.32, P = 4.55 x 10(-9)) and rs414580 (intron 2 of MSR1, chr 8p22, P = 6.09 x 10(-8)) were significantly associated with ALL.
Our data suggest that inefficient folding of SR-AI variants with truncated SRCR domain was recognized by the endoplasmic reticulum associated degradation which leads to the immature N- glycosylation and intracellular retention
Our findings demonstrated that ClC-3 (show CLCN3 Antibodies) deficiency inhibits atherosclerotic lesion development, possibly via suppression of JNK (show MAPK8 Antibodies)/p38 MAPK (show MAPK14 Antibodies) dependent SR-A expression and foam cell formation
FAP (show FAP Antibodies)-cleaved collagen is a substrate for SR-A-dependent macrophage adhesion.
Macrophages regulate FX plasma levels in an SR-AI-dependent manner.
The results of this results reveal that SRA has important clinical implications for TLR-targeted immunotherapeutical strategy in intracerebral hemorrhage.
these findings suggest that SR-A-mediated dsRNA internalization is independent of innate antiviral signaling.
Our findings imply that SR-A may be an important target for improving therapeutic strategies for type 1 diabetes.
Heptapeptide XD4 activates the class A scavenger receptor (SR-A) on the glia by increasing the binding of Abeta (show APP Antibodies) to SR-A, thereby promoting glial phagocytosis of Abeta (show APP Antibodies) oligomer in an immortalized microglia cell line.
SR-A does not induce cytokine production, but mediates inhibition of LPS (show TLR4 Antibodies)-stimulated production of IL-6 (show IL6 Antibodies) and IL-12 (show IL12A Antibodies)
The antagonism between SR-A and RAGE (show AGER Antibodies) contributes to the pathogenesis of diabetic retinopathy by nurturing a disease-prone macrophage phenotype.
our data indicate that SR-A localizes in LRs (show LARS Antibodies) and that LRs (show LARS Antibodies) are required to couple SR-A to PLA2 (show PLA2G2A Antibodies) activation during SRA-mediated macrophage attachment.
This gene encodes the class A macrophage scavenger receptors, which include three different types (1, 2, 3) generated by alternative splicing of this gene. These receptors or isoforms are macrophage-specific trimeric integral membrane glycoproteins and have been implicated in many macrophage-associated physiological and pathological processes including atherosclerosis, Alzheimer's disease, and host defense. The isoforms type 1 and type 2 are functional receptors and are able to mediate the endocytosis of modified low density lipoproteins (LDLs). The isoform type 3 does not internalize modified LDL (acetyl-LDL) despite having the domain shown to mediate this function in the types 1 and 2 isoforms. It has an altered intracellular processing and is trapped within the endoplasmic reticulum, making it unable to perform endocytosis. The isoform type 3 can inhibit the function of isoforms type 1 and type 2 when co-expressed, indicating a dominant negative effect and suggesting a mechanism for regulation of scavenger receptor activity in macrophages.
macrophage scavenger receptor 1
, macrophage scavenger receptor types I and II-like
, macrophage acetylated LDL receptor I and II
, macrophage scavenger receptor type III
, macrophage scavenger receptor types I and II
, scavenger receptor class A member 1
, scavenger receptor class A, member 1
, scavenger receptor type A
, macrophage scavenger receptor type I